Message from President
Pola Pharma has become a member of Sun Pharma group, effective January 1, 2019.
Pola Pharma was established in 2007 as an ethical pharmaceutical company dedicated to the field of dermatology and has been engaged in research and development, manufacturing and sales centered on dermatological medicines.
Sun Pharma group, headquartered in India, is one of the world leading specialty generic pharmaceutical company. With R&D investments focused on the dermatology, oncology and ophthalmology, Sun Pharma has grown into a company that currently ranks high in United States dermatology field. By combining strengths of Sun Pharma's Global portfolio, R&D capabilities, know-how and our established expertise in Japan market, Pola Pharma will further strengthen progress towards becoming one of the leading specialty pharmaceutical companies focused on the dermatological field in Japan.
We believes that skin is one of the most beautiful organ which protects us from external threats and deepens our communication through contact. Through R&D, manufacturing and sales of medicines related to skin diseases, which play an important role in this field, Pola Pharma aims to support the patients by providing a broad range of treatment options to doctors.